Literature DB >> 9488039

Identification of cdk2 binding sites on the p27Kip1 cyclin-dependent kinase inhibitor.

T K Kwon1, A A Nordin.   

Abstract

A cdk2 binding domain on p27Kip1 located within the sequence of amino acids 53-85 was further characterized by generating a series of point mutations within amino acid residues 62-75. Two regions, FDF (residues 62-64) and GXY (residues 72 and 74), were identified within the beta hairpin region of p27Kip1. Mutations within these regions essentially completely inhibited the binding to in vitro translated cdk2 and cdk2/cyclin E complexes formed in vitro or in vivo. The p27Kip1 GST-fusion protein of the point mutation that replaces phenylalanine at residue 64 to alanine (F64A) showed approximately twofold less inhibition of cdk2 kinase activity. The cellular response to the introduction of the F64A mutant form of p27Kip1 was compared to that of p27Kip1 wild type by transfecting HeLa cells with constructs of full length sense and antisense coding sequences. Overexpression of the F64A mutant form of p27Kip1 bound significantly lower levels of cdk2 as compared to wild type and did not affect the cdk2 related kinase activity of the transfected HeLa cells. Overexpression of wild type p27Kip1 resulted in a reduction of the level of cdk2 kinase activity and effectively suppressed the growth of the transfected HeLa cells.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9488039     DOI: 10.1038/sj.onc.1201586

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  6 in total

1.  A theory for controlling cell cycle dynamics using a reversibly binding inhibitor.

Authors:  T S Gardner; M Dolnik; J J Collins
Journal:  Proc Natl Acad Sci U S A       Date:  1998-11-24       Impact factor: 11.205

2.  p27(Kip1) induction and inhibition of proliferation by the intracellular Ah receptor in developing thymus and hepatoma cells.

Authors:  S K Kolluri; C Weiss; A Koff; M Göttlicher
Journal:  Genes Dev       Date:  1999-07-01       Impact factor: 11.361

3.  Rare germline mutations in cyclin-dependent kinase inhibitor genes in multiple endocrine neoplasia type 1 and related states.

Authors:  Sunita K Agarwal; Carmen M Mateo; Stephen J Marx
Journal:  J Clin Endocrinol Metab       Date:  2009-01-13       Impact factor: 5.958

4.  SNR1 (INI1/SNF5) mediates important cell growth functions of the Drosophila Brahma (SWI/SNF) chromatin remodeling complex.

Authors:  Claudia B Zraly; Daniel R Marenda; Andrew K Dingwall
Journal:  Genetics       Date:  2004-09       Impact factor: 4.562

5.  Cancer-associated splicing variant of tumor suppressor AIMP2/p38: pathological implication in tumorigenesis.

Authors:  Jin Woo Choi; Dae Gyu Kim; Al-Eum Lee; Hye Rim Kim; Jin Young Lee; Nam Hoon Kwon; Young Kee Shin; Soon-Kyung Hwang; Seung-Hee Chang; Myung-Haing Cho; Yoon-La Choi; Jhingook Kim; Seung Hyun Oh; Bora Kim; Soo-Youl Kim; Hyo-Sung Jeon; Jae Yong Park; Hyunseok Peter Kang; Bum Joon Park; Jung Min Han; Sunghoon Kim
Journal:  PLoS Genet       Date:  2011-03-31       Impact factor: 5.917

6.  The novel protective role of P27 in MLN4924-treated gastric cancer cells.

Authors:  Q Zhang; D Hou; Z Luo; P Chen; B Lv; L Wu; Y Ma; Y Chu; H Liu; F Liu; S Yu; J Zhang; D Yang; J Liu
Journal:  Cell Death Dis       Date:  2015-08-27       Impact factor: 8.469

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.